Cancer Models

products-servicesPharmatest Services Ltd
May 20th 2014

The Pharmatest preclinical contract research organization (CRO) offers full-service efficacy testing of new cancer drug candidates. Its cancer models include in vitro cell culture assays and animal models of breast cancer, prostate cancer, pancreatic cancer and multiple myeloma.

These cancer cell cultures can be conveniently used for identifying compounds with best efficacy for subsequent testing in animal studies.

Animal models

Pharmatest has a number of cancer animal models immediately available in the four principal categories:

Breast Cancer

Cell Line Type Route Metastasis
MDA-MB-231(SA) Xenograft Intracardiac Bone
MDA-MB-231(SA) Xenograft Orthotopic Lung, Lymph nodes
MCF-7 Xenograft Orthotopic None
4T1 Syngeneic Intracardiac Bone
4T1 Syngeneic Orthotopic Lung, Liver, Lymph nodes

Prostate Cancer

Cell LineTypeRouteMetastasis

PC3 Xenograft Intracardiac Bone
PC3 Xenograft Intratibial Bone
PC3 Xenograft Orthotopic Lymph nodes
LNCaP Xenograft Orthotopic None
LNCaP Xenograft Intratibial Bone
VCaP Xenograft Intratibial Bone

Pancreatic Cancer

Cell LineTypeRouteMetastasis

BxPC3 Xenograft Orthotopic None

Blood/Multiple myeloma

Cell LineTypeRouteMetastasis

5TGM1 Syngeneic Tail vein Bone

 

In addition to the models listed above, several other cancer cell lines are available for use in Pharmatest cancer in vitro assays.

Resources

Click on Cancer Models for other information.
Click on Pharmatest to contact the company directly.


Supplier Information
Supplier: Pharmatest Services Ltd
Address: Itäinen Pitkäkatu 4 C, 5th floor, 20520 Turku, Finland
Tel: +358 2 278 4700
Fax: +358 2 278 4710
Website: www.pharmatest.com